Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 525

1.

A novel chalcone derivative as Nrf2 activator attenuates learning and memory impairment in a scopolamine-induced mouse model.

Kim HJ, Jang BK, Park JH, Choi JW, Park SJ, Byeon SR, Pae AN, Lee YS, Cheong E, Park KD.

Eur J Med Chem. 2019 Oct 12;185:111777. doi: 10.1016/j.ejmech.2019.111777. [Epub ahead of print]

PMID:
31670201
2.

Lock-in Amplifier-Based Impedance Detection of Tissue Type Using a Monopolar Injection Needle.

Kim J, Abbasi MA, Kim T, Park KD, Cho S.

Sensors (Basel). 2019 Oct 23;19(21). pii: E4614. doi: 10.3390/s19214614.

3.

Negative myoclonus associated with pregabalin.

Park KD, Kim MK, Lee SJ.

Yeungnam Univ J Med. 2018 Dec;35(2):240-243. doi: 10.12701/yujm.2018.35.2.240. Epub 2018 Dec 31.

4.

Removal of fluoride in membrane-based water and wastewater treatment technologies: Performance review.

Damtie MM, Woo YC, Kim B, Hailemariam RH, Park KD, Shon HK, Park C, Choi JS.

J Environ Manage. 2019 Dec 1;251:109524. doi: 10.1016/j.jenvman.2019.109524. Epub 2019 Sep 19. Review.

PMID:
31542619
5.

Subacute Combined Degeneration Caused by Nitrous Oxide Intoxication: A Report of Two Cases.

Choi C, Kim T, Park KD, Lim OK, Lee JK.

Ann Rehabil Med. 2019 Aug;43(4):530-534. doi: 10.5535/arm.2019.43.4.530. Epub 2019 Aug 31.

6.

Proteomic analysis of the skeletal muscles from dysferlinopathy patients.

Choi YC, Hong JM, Park KD, Shin HY, Kim SM, Park HJ.

J Clin Neurosci. 2019 Aug 19. pii: S0967-5868(19)31210-X. doi: 10.1016/j.jocn.2019.08.068. [Epub ahead of print]

PMID:
31439488
7.

Activation of Astrocytic μ-Opioid Receptor Causes Conditioned Place Preference.

Nam MH, Han KS, Lee J, Won W, Koh W, Bae JY, Woo J, Kim J, Kwong E, Choi TY, Chun H, Lee SE, Kim SB, Park KD, Choi SY, Bae YC, Lee CJ.

Cell Rep. 2019 Jul 30;28(5):1154-1166.e5. doi: 10.1016/j.celrep.2019.06.071.

8.

Three new decenynol glucosides from Artemisia scoparia (Asteraceae).

Cho JY, Park KH, Hwang DY, Lee SY, Moon JH, Ju Lee Y, Park KD, Ham KS.

J Asian Nat Prod Res. 2019 Jul 30:1-8. doi: 10.1080/10286020.2019.1646729. [Epub ahead of print]

PMID:
31359770
9.

Discovery of Novel Biased Opioid Receptor Ligands through Structure-Based Pharmacophore Virtual Screening and Experiment.

Jeong P, Kim SK, Li Q, Oh SJ, Son S, Chen G, Tan H, Kim S, Park JH, Park KD, Kim YO, Yoon MH, Kim YC, Goddard WA 3rd.

ChemMedChem. 2019 Oct 17;14(20):1783-1794. doi: 10.1002/cmdc.201900418. Epub 2019 Sep 26.

PMID:
31359587
10.

Tandem high-dose chemotherapy with topotecan-thiotepa-carboplatin and melphalan-etoposide-carboplatin regimens for pediatric high-risk brain tumors.

Choi JY, Kang HJ, Hong KT, Hong CR, Lee YJ, Park JD, Phi JH, Kim SK, Wang KC, Kim IH, Park SH, Choi YH, Cheon JE, Park KD, Shin HY.

Int J Clin Oncol. 2019 Jul 27. doi: 10.1007/s10147-019-01517-8. [Epub ahead of print]

PMID:
31352632
11.

Comparison of tube feeding in stroke patients: Nasogastric tube feeding versus oroesophageal tube feeding-A pilot study.

Park JW, Park KD, Kim TH, Lee JY, Lim OK, Lee JK, Choi C.

Medicine (Baltimore). 2019 Jul;98(30):e16472. doi: 10.1097/MD.0000000000016472.

12.

Upfront chemotherapy followed by response adaptive radiotherapy for intracranial germinoma: Prospective multicenter cohort study.

Lee DS, Lim DH, Kim IH, Kim JY, Han JW, Yoo KH, Park KD, Park HJ, Chung NG, Suh CO, Kim DS.

Radiother Oncol. 2019 Sep;138:180-186. doi: 10.1016/j.radonc.2019.06.002. Epub 2019 Jul 15.

PMID:
31319280
13.

Antioxidant, Anti-inflammatory, and Neuroprotective Effects of Novel Vinyl Sulfonate Compounds as Nrf2 Activator.

Choi JW, Shin SJ, Kim HJ, Park JH, Kim HJ, Lee EH, Pae AN, Bahn YS, Park KD.

ACS Med Chem Lett. 2019 Jun 3;10(7):1061-1067. doi: 10.1021/acsmedchemlett.9b00163. eCollection 2019 Jul 11.

PMID:
31312409
14.

Membrane-based technologies for zero liquid discharge and fluoride removal from industrial wastewater.

Damtie MM, Hailemariam RH, Woo YC, Park KD, Choi JS.

Chemosphere. 2019 Dec;236:124288. doi: 10.1016/j.chemosphere.2019.07.019. Epub 2019 Jul 5.

PMID:
31310982
15.

Tip-enhanced strong coupling spectroscopy, imaging, and control of a single quantum emitter.

Park KD, May MA, Leng H, Wang J, Kropp JA, Gougousi T, Pelton M, Raschke MB.

Sci Adv. 2019 Jul 12;5(7):eaav5931. doi: 10.1126/sciadv.aav5931. eCollection 2019 Jul.

16.

Analysis of mass transfer behavior in membrane distillation: Mathematical modeling under various conditions.

Damtie MM, Woo YC, Kim B, Park KD, Hailemariam RH, Shon HK, Choi JS.

Chemosphere. 2019 Dec;236:124289. doi: 10.1016/j.chemosphere.2019.07.020. Epub 2019 Jul 8.

PMID:
31306977
17.

Validity and reliability of itch assessment scales for chronic pruritus in adults: A prospective multicenter study.

Jang YH, Kim SM, Eun DH, Park KD, Park GH, Kim BS, Li K, Park CO, Kim HO, Kim HS, Jang MS, Doh EJ, Lee DH, Lee YW, Kim DW, Kim SJ.

J Am Acad Dermatol. 2019 Jun 27. pii: S0190-9622(19)31042-4. doi: 10.1016/j.jaad.2019.06.043. [Epub ahead of print]

PMID:
31255747
18.

Graphene oxide immobilized surfaces facilitate the sustained release of doxycycline for the prevention of implant related infection.

Tran DL, Le Thi P, Hoang Thi TT, Park KD.

Colloids Surf B Biointerfaces. 2019 Sep 1;181:576-584. doi: 10.1016/j.colsurfb.2019.06.009. Epub 2019 Jun 5.

PMID:
31195313
19.

Molecular diagnosis of hereditary spherocytosis by multi-gene target sequencing in Korea: matching with osmotic fragility test and presence of spherocyte.

Choi HS, Choi Q, Kim JA, Im KO, Park SN, Park Y, Shin HY, Kang HJ, Kook H, Kim SY, Kim SJ, Kim I, Kim JY, Kim H, Park KD, Park KB, Park M, Park SK, Park ES, Park JA, Park JE, Park JK, Baek HJ, Seo JH, Shim YJ, Ahn HS, Yoo KH, Yoon HS, Won YW, Lee KS, Lee KC, Lee MJ, Lee SA, Lee JA, Lee JM, Lee JH, Lee JW, Lim YT, Jung HJ, Chueh HW, Choi EJ, Jung HL, Kim JH, Lee DS; Hereditary Hemolytic Anemia Working Party of the Korean Society of Hematology.

Orphanet J Rare Dis. 2019 May 23;14(1):114. doi: 10.1186/s13023-019-1070-0.

20.

Tropomyosin-receptor kinase fused gene (TFG) regulates lipid production in human sebocytes.

Choi SR, Hwang YL, Kim SJ, Sohn KC, Choi CW, Park KD, Lee Y, Seo YJ, Lee JH, Hong SP, Seo SJ, Kim SJ, Kim CD.

Sci Rep. 2019 Apr 29;9(1):6587. doi: 10.1038/s41598-019-43209-3.

21.

Targeting the CaVα-CaVβ interaction yields an antagonist of the N-type CaV2.2 channel with broad antinociceptive efficacy.

Khanna R, Yu J, Yang X, Moutal A, Chefdeville A, Gokhale V, Shuja Z, Chew LA, Bellampalli SS, Luo S, François-Moutal L, Serafini MJ, Ha T, Perez-Miller S, Park KD, Patwardhan AM, Streicher JM, Colecraft HM, Khanna M.

Pain. 2019 Jul;160(7):1644-1661. doi: 10.1097/j.pain.0000000000001524.

PMID:
30933958
22.

Newly developed reversible MAO-B inhibitor circumvents the shortcomings of irreversible inhibitors in Alzheimer's disease.

Park JH, Ju YH, Choi JW, Song HJ, Jang BK, Woo J, Chun H, Kim HJ, Shin SJ, Yarishkin O, Jo S, Park M, Yeon SK, Kim S, Kim J, Nam MH, Londhe AM, Kim J, Cho SJ, Cho S, Lee C, Hwang SY, Kim SW, Oh SJ, Cho J, Pae AN, Lee CJ, Park KD.

Sci Adv. 2019 Mar 20;5(3):eaav0316. doi: 10.1126/sciadv.aav0316. eCollection 2019 Mar.

23.

Functional Magnetic Core-Shell System-Based Iron Oxide Nanoparticle Coated with Biocompatible Copolymer for Anticancer Drug Delivery.

Hoang Thi TT, Nguyen Tran DH, Bach LG, Vu-Quang H, Nguyen DC, Park KD, Nguyen DH.

Pharmaceutics. 2019 Mar 15;11(3). pii: E120. doi: 10.3390/pharmaceutics11030120.

24.

Comparative transcriptome analysis of skeletal muscle in ADSSL1 myopathy.

Park HJ, Hong JM, Lee JH, Shin HY, Kim SM, Park KD, Lee JH, Choi YC.

Neuromuscul Disord. 2019 Apr;29(4):274-281. doi: 10.1016/j.nmd.2018.11.003. Epub 2018 Nov 22.

PMID:
30853170
25.

Thromboembolism in children with cancer: a retrospective multicenter study in Korea.

Choi HS, Kim HJ, Kang HJ, Lee JW, Shin HY, Park HJ, Park BK, Lee YH, Lee JA, Lim YJ, Park KD.

J Thromb Thrombolysis. 2019 May;47(4):558-565. doi: 10.1007/s11239-019-01808-x.

PMID:
30666552
26.

In Situ Cross-Linkable Hydrogels as a Dynamic Matrix for Tissue Regenerative Medicine.

Park KM, Park KD.

Tissue Eng Regen Med. 2018 Aug 27;15(5):547-557. doi: 10.1007/s13770-018-0155-5. eCollection 2018 Oct. Review.

27.

Foundation of pediatric cancer treatment in Lao People's Democratic Republic at the Lao-Korea National Children's Hospital.

Park KD, Hong CR, Choi JY, Kim MS, Yi ES, Saysouliyo S, Phongsavath K, Shin HY.

Pediatr Hematol Oncol. 2018 May;35(4):268-275. doi: 10.1080/08880018.2018.1477888. Epub 2018 Dec 31.

PMID:
30595064
28.

Phosphorylated CRMP2 Regulates Spinal Nociceptive Neurotransmission.

Yu J, Moutal A, Dorame A, Bellampalli SS, Chefdeville A, Kanazawa I, Pham NYN, Park KD, Weimer JM, Khanna R.

Mol Neurobiol. 2019 Jul;56(7):5241-5255. doi: 10.1007/s12035-018-1445-6. Epub 2018 Dec 18.

PMID:
30565051
29.

Optimization of Vinyl Sulfone Derivatives as Potent Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Activators for Parkinson's Disease Therapy.

Choi JW, Kim S, Park JH, Kim HJ, Shin SJ, Kim JW, Woo SY, Lee C, Han SM, Lee J, Pae AN, Han G, Park KD.

J Med Chem. 2019 Jan 24;62(2):811-830. doi: 10.1021/acs.jmedchem.8b01527. Epub 2018 Dec 20.

PMID:
30540174
30.
31.

First-in-class DAPK1/CSF1R dual inhibitors: Discovery of 3,5-dimethoxy-N-(4-(4-methoxyphenoxy)-2-((6-morpholinopyridin-3-yl)amino)pyrimidin-5-yl)benzamide as a potential anti-tauopathies agent.

Farag AK, Hassan AHE, Jeong H, Kwon Y, Choi JG, Oh MS, Park KD, Kim YK, Roh EJ.

Eur J Med Chem. 2019 Jan 15;162:161-175. doi: 10.1016/j.ejmech.2018.10.057. Epub 2018 Nov 2.

PMID:
30445265
32.

The Novel Neuroprotective Compound KMS99220 Has an Early Anti-neuroinflammatory Effect via AMPK and HO-1, Independent of Nrf2.

Lee JA, Kim HR, Kim J, Park KD, Kim DJ, Hwang O.

Exp Neurobiol. 2018 Oct;27(5):408-418. doi: 10.5607/en.2018.27.5.408. Epub 2018 Oct 31.

33.

Endoscopic botulinum toxin injection for treatment of pharyngeal dysphagia in patients with cricopharyngeal dysfunction.

Jeong SH, Kim YJ, Kim YJ, Park KD, Kim EJ, Chung JW, Kwon KA, Kim KO, Park DK, Kim JH, Cho JH.

Scand J Gastroenterol. 2018 Oct - Nov;53(10-11):1201-1205. doi: 10.1080/00365521.2018.1506820. Epub 2018 Oct 24.

PMID:
30353754
34.
35.

Synthesis of oxidative metabolites of CRA13 and their analogs: Identification of CRA13 active metabolites and analogs thereof with selective CB2R affinity.

Hassan AHE, Cho MC, Kim HI, Yang JS, Park KT, Hwang JY, Jang CG, Park KD, Lee YS.

Bioorg Med Chem. 2018 Oct 1;26(18):5069-5078. doi: 10.1016/j.bmc.2018.09.007. Epub 2018 Sep 6.

PMID:
30217464
36.

Origin and spread of Thoroughbred racehorses inferred from complete mitochondrial genome sequences: Phylogenomic and Bayesian coalescent perspectives.

Yoon SH, Lee W, Ahn H, Caetano-Anolles K, Park KD, Kim H.

PLoS One. 2018 Sep 14;13(9):e0203917. doi: 10.1371/journal.pone.0203917. eCollection 2018.

37.

Catechol-rich gelatin hydrogels in situ hybridizations with silver nanoparticle for enhanced antibacterial activity.

Le Thi P, Lee Y, Hoang Thi TT, Park KM, Park KD.

Mater Sci Eng C Mater Biol Appl. 2018 Nov 1;92:52-60. doi: 10.1016/j.msec.2018.06.037. Epub 2018 Jun 19.

PMID:
30184778
38.

Enhanced articular cartilage regeneration with SIRT1-activated MSCs using gelatin-based hydrogel.

Choi SM, Lee KM, Ryu SB, Park YJ, Hwang YG, Baek D, Choi Y, Park KH, Park KD, Lee JW.

Cell Death Dis. 2018 Aug 29;9(9):866. doi: 10.1038/s41419-018-0914-1.

39.

Therapeutic Effect of Controlled Release of Dual Growth Factor Using Heparin-Pluronic Hydrogel/Gelatin-Poly (Ethylene Glycol)-Tyramine Hydrogel System in a Rat Model of Cavernous Nerve Injury.

Jung AR, Park YH, Jeon SH, Kim GE, Kim MY, Son JY, Ha US, Hong SH, Kim SW, Park KD, Lee JY.

Tissue Eng Part A. 2018 Dec;24(23-24):1705-1714. doi: 10.1089/ten.TEA.2017.0469. Epub 2018 Oct 29.

PMID:
30152718
40.

Analysis of genetic characteristics of pig breeds using information on single nucleotide polymorphisms.

Lee SM, Oh JD, Park KD, Do KT.

Asian-Australas J Anim Sci. 2019 Apr;32(4):485-493. doi: 10.5713/ajas.18.0304. Epub 2018 Aug 27.

41.

Mammalian target of rapamycin complex 1 and its downstream effector collapsin response mediator protein-2 drive reinstatement of alcohol reward seeking.

Ben Hamida S, Laguesse S, Morisot N, Park JH, Phuamluong K, Berger AL, Park KD, Ron D.

Addict Biol. 2019 Sep;24(5):908-920. doi: 10.1111/adb.12653. Epub 2018 Jul 18.

42.

High- versus low-energy extracorporeal shock-wave therapy for myofascial pain syndrome of upper trapezius: A prospective randomized single blinded pilot study.

Park KD, Lee WY, Park MH, Ahn JK, Park Y.

Medicine (Baltimore). 2018 Jul;97(28):e11432. doi: 10.1097/MD.0000000000011432.

43.

Favorable Outcome of Post-Transplantation Cyclophosphamide Haploidentical Peripheral Blood Stem Cell Transplantation with Targeted Busulfan-Based Myeloablative Conditioning Using Intensive Pharmacokinetic Monitoring in Pediatric Patients.

Hong KT, Kang HJ, Choi JY, Hong CR, Cheon JE, Park JD, Park KD, Song SH, Yu KS, Jang IJ, Shin HY.

Biol Blood Marrow Transplant. 2018 Nov;24(11):2239-2244. doi: 10.1016/j.bbmt.2018.06.034. Epub 2018 Jul 6.

44.

Tonsil-derived mesenchymal stem cell-embedded in situ crosslinkable gelatin hydrogel therapy recovers postmenopausal osteoporosis through bone regeneration.

Kim G, Park YS, Lee Y, Jin YM, Choi DH, Ryu KH, Park YJ, Park KD, Jo I.

PLoS One. 2018 Jul 5;13(7):e0200111. doi: 10.1371/journal.pone.0200111. eCollection 2018.

45.

Thyroid dysfunction in patients with childhood-onset medulloblastoma or primitive neuroectodermal tumor.

Jin SY, Choi JY, Park KD, Kang HJ, Shin HY, Phi JH, Kim SK, Wang KC, Kim IH, Lee YA, Shin CH, Yang SW.

Ann Pediatr Endocrinol Metab. 2018 Jun;23(2):88-93. doi: 10.6065/apem.2018.23.2.88. Epub 2018 Jun 20.

46.

School performance of childhood cancer survivors in Korea: A multi-institutional study on behalf of the Korean Society of Pediatric Hematology and Oncology.

Park M, Park HJ, Lee JM, Ju HY, Park BK, Yu ES, Yang HK, Kim JY, Park SK, Lee YH, Shim YJ, Kim HS, Lee JA, Lim YJ, Cheuh HW, Park JK, Lee MJ, Kim SK, Choi HS, Hah JO, Park KD, Kang HJ, Shin HY.

Psychooncology. 2018 Sep;27(9):2257-2264. doi: 10.1002/pon.4819. Epub 2018 Jul 12.

PMID:
29927510
47.

Successful Treatment of Pediatric Epstein-Barr Virus-positive Aggressive Natural Killer-Cell Leukemia.

Kim BK, Hong KT, Kang HJ, An HY, Choi JY, Hong CR, Park KD, Lee DS, Shin HY.

J Pediatr Hematol Oncol. 2019 Jul;41(5):e336-e337. doi: 10.1097/MPH.0000000000001237.

PMID:
29889803
48.

Risk Factor Analysis for Secondary Malignancy in Dexrazoxane-Treated Pediatric Cancer Patients.

Kim H, Kang HJ, Park KD, Koh KN, Im HJ, Seo JJ, Lee JW, Chung NG, Cho B, Kim HK, Lee JM, Hah JO, Lee JA, Lee YH, Park SK, Baek HJ, Kook H, Kim JY, Kim HS, Kim HM, Chueh HW, Park M, Yoon HS, Lee MJ, Choi HS, Ahn HS, Kawano Y, Park JW, Hahn S, Shin HY.

Cancer Res Treat. 2019 Jan;51(1):357-367. doi: 10.4143/crt.2017.457. Epub 2018 May 14.

49.

Hydrogen Peroxide-Releasing Hydrogels for Enhanced Endothelial Cell Activities and Neovascularization.

Lee Y, Son JY, Kang JI, Park KM, Park KD.

ACS Appl Mater Interfaces. 2018 May 30;10(21):18372-18379. doi: 10.1021/acsami.8b04522. Epub 2018 May 16.

PMID:
29722526
50.

Partial Conduction Block as an Early Nerve Conduction Finding in Neurolymphomatosis.

Park HJ, Shin HY, Kim SH, Jeong HN, Choi YC, Suh BC, Park KD, Kim SM.

J Clin Neurol. 2018 Jan;14(1):73-80. doi: 10.3988/jcn.2018.14.1.73.

Supplemental Content

Support Center